International research suggests that a simple in vitro
bioassay, in addition to procedures currently in place, would help
secure the global supply chain for heparin and reduce the risk of
patients being exposed to harmful contaminants.
The US Food and Drug Administration (FDA) believes that the
contamination of Baxter's blood thinner heparin, which has been
linked to 62 deaths in the US, may have been due to the deliberate
replacement of some ingredients with...
China's drug regulatory authority is finally responding to curb its
damaged reputation by urging its local authorities to take a more
proactive role in stemming what is fast becoming a global heparin
contamination, sparked by...
The heparin recall has widened after a lot of heparin sodium USP
active pharmaceutical ingredient (API) produced by Scientific
Protein Laboratories (SPL) was found to contain a heparin-like
A US Food and Drug Administration (FDA) investigation into the
recent Baxter heparin scare has uncovered a contaminant in the
product that was sourcing the active pharmaceutical ingredient
(API) from a Chinese manufacturer.